On Monday, Canaccord Genuity adjusted its price target for 10X Genomics (NASDAQ: TXG) shares, lowering it to $15.00 from the previous $18.00, while still maintaining a Buy rating on the stock ...

NXT drew a 0.15 rating in the 18-49 demo. That’s up 7.1 percent from last week but ties the third-lowest rating the show has done in that category for the year to date. NXT tied for eighth on ...

Stifel Financial operates as the bank holding company for Stifel, Nicolaus & Company. Read why SF stock's preferreds offer ...

Pollster G. Elliott Morris' tracker shows that on the issue of the economy, Trump's approval rating is underwater by 15.75 ...

Former NBA player Ron Harper was part of two of the greatest teams in NBA history, the 1995-96 Chicago Bulls and the 2000-01 Los Angeles Lakers. There are few more qualified to speak about those teams ...

A wildfire burning south of Sproat Lake near Port Alberni grew overnight to 15 hectares and is suspected to have been human-caused.

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Here are 15 health systems that recently had their outlooks upgraded by Fitch Ratings or Moody’s Investors Service in 2025. Note: This is not an exhaustive list. Health systems were compiled from ...

Ole Miss track & field moved up to No. 15 in the Week Nine USTFCCCA Outdoor Rating Index released Tuesday morning. Only marks ...

Broadcom’s AI revenue is booming with strong demand and buybacks boosting value, signaling more upside ahead. See why AVGO ...

President Donald Trump’s approval rating has improved slightly since dropping after his tariff trade wars that caused the stock market to sink.

Benchmark analysts have initiated coverage on Kamada with a Buy rating and set a price target of $15.00, highlighting the company’s growth in its plasma-derived product line.